Back Issue Descriptions to Volume 7

Forefront Vol. 7, No. 1, Issue #32, February 1992

Medical Forefronts in AIDS: Strategies for Whole-Scale Immune System Reconstitution, by P. A. Sergios (a thorough discussion of current and proposed techniques for rebuilding human immune systems compromised by immune deficiency); Premenstrual Syndrome, by Ward Dean, M.D. (clinical use of a neuroendocrine approach to PMS); Ask MegaHealth (Psychotonin M claims from the Dallas Buyer's Club); New Research on DHEA (the association between a steroid aging biomarker and the development of AIDS); Soluble Melanin Synthesis (simple step-by-step procedure).

Forefront Vol. 7, No. 2, Issue #33, July 1992

Medical Forefronts: Tryptophan Metabolism in Chronic Disease and AIDS, by Steven Wm. Fowkes (the influence of infection-induced tryptophan deficiency in chronic diseases and strategies for treatment); Medical Forefronts: Evaluating Anti-Viral and Immunomodulatory Treatment Strategies in HIV Disease, by P. A. Sergios, Ph.D. (Part 1: Antiviral Strategies for the treatment of HIV disease -- Part 2: Immunomodulatory Strategies to follow in the next issue).

Forefront Vol. 7, No. 3, Issue #34, November 1992

Legislative Update: Health Freedom in Our Time, by Steven Wm. Fowkes (the FDA's war on health freedom in America is exposed and solutions are presented); Medical Forefronts: Evaluating Anti-Viral and Immunomodulatory Treatment Strategies in HIV Disease, by P. A. Sergios, Ph.D. (Part 2: Immunomodulatory Strategies -- including cytokines, hormones, drugs, vaccines, and immunotherapies); Editorial: Does the FDA Need Smart Drugs? by Ward Dean, M.D. (a response to the FDA's Talk Paper on smart drugs, with statistical data on comparable death rates from vitamins vs drugs); book announcement (STOP the FDA: Save Your Health Freedom, by John Morgenthaler and Steven Wm. Fowkes, just published).

Forefront Vol. 7, No. 4, Issue #35, August 1993

Health Hypotheses: Antioxidants, Antibodies and Autoimmune Disease, by Steven Wm. Fowkes (the role of free radicals and oxidation-reduction potential in the functioning of the immune system); Editorial: Proposed Health Freedom Legislation, by Steven Wm. Fowkes (an analysis of the three bills in the 1992 Congress that are intended to solve the FDA problem); The Stepwise Oxidation of Ethane (an illustrated example of the chemistry of oxidation); Redox Potential and Oxidative Stress (how redox potential diffuses from a site of injury); The Three Faces of Vitamin C (three distinct therapeutic applications for vitamin C).

Forefront Vol. 7, No. 5, Issue #36, August 1994

Buyer’s Club News: What’s New on the AIDS Underground, by Paul A. Sergios (Paul’s last article for Forefront about oral and injectable acemannan, Carrington Laboratories, DNCB, bitter melon, trichosanthin “Compound Q,” curcumin, the TAT inhibitors, Peptide T and the FDA); Policy Proposal: Dr. Dean’s Health-Care Reform Plan, by Ward Dean, M.D. (a freedom-oriented alternative to the Clinton’s health-care proposals); TAT Inhibitor Drugs (an illustration); Buyer’s Clubs Contact Information (a sidebar); The Clinton “Simplified” Health-Care Plan (an illustration).

Forefront Vol. 7, No. 6, Issue #37, April 1995

Medical Forefronts: Thalidomide for AIDS, KS and Cancer, by Charles Davidson (applications of thalidomide to angiogenesis, tumor necrosis factor, oxidative stress, AIDS, Kaposi’s sarcoma and cancer); Anti-HIV Drugs from Other Fields of Medicine: LTR Inhibitors, by Charles Davidson (long terminal repeat, NFkappaB and HIV replication); Thalidomide (an illustration); Free Radicals (a side bar); Monitoring TNF Levels (a side bar); Thalidomide Dosage (a side bar discussing dosage, neuropathy and other side effects).

Go to the back issues page or home page.